1. Home
  2. BYON vs FTRE Comparison

BYON vs FTRE Comparison

Compare BYON & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYON
  • FTRE
  • Stock Information
  • Founded
  • BYON 1997
  • FTRE 1996
  • Country
  • BYON United States
  • FTRE United States
  • Employees
  • BYON N/A
  • FTRE N/A
  • Industry
  • BYON Catalog/Specialty Distribution
  • FTRE Medical Specialities
  • Sector
  • BYON Consumer Discretionary
  • FTRE Health Care
  • Exchange
  • BYON Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • BYON 468.4M
  • FTRE 468.1M
  • IPO Year
  • BYON N/A
  • FTRE N/A
  • Fundamental
  • Price
  • BYON $8.18
  • FTRE $6.35
  • Analyst Decision
  • BYON Hold
  • FTRE Hold
  • Analyst Count
  • BYON 9
  • FTRE 11
  • Target Price
  • BYON $11.00
  • FTRE $14.40
  • AVG Volume (30 Days)
  • BYON 3.8M
  • FTRE 1.9M
  • Earning Date
  • BYON 07-28-2025
  • FTRE 08-06-2025
  • Dividend Yield
  • BYON N/A
  • FTRE N/A
  • EPS Growth
  • BYON N/A
  • FTRE N/A
  • EPS
  • BYON N/A
  • FTRE N/A
  • Revenue
  • BYON $1,128,578,000.00
  • FTRE $2,685,600,000.00
  • Revenue This Year
  • BYON N/A
  • FTRE N/A
  • Revenue Next Year
  • BYON $13.21
  • FTRE $0.97
  • P/E Ratio
  • BYON N/A
  • FTRE N/A
  • Revenue Growth
  • BYON N/A
  • FTRE N/A
  • 52 Week Low
  • BYON $3.54
  • FTRE $3.97
  • 52 Week High
  • BYON $12.24
  • FTRE $26.59
  • Technical
  • Relative Strength Index (RSI)
  • BYON 46.75
  • FTRE 48.21
  • Support Level
  • BYON $6.99
  • FTRE $6.17
  • Resistance Level
  • BYON $11.11
  • FTRE $6.90
  • Average True Range (ATR)
  • BYON 0.95
  • FTRE 0.52
  • MACD
  • BYON -0.19
  • FTRE 0.03
  • Stochastic Oscillator
  • BYON 25.00
  • FTRE 41.10

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad number of products, including furniture, decor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: